Jiwon Huh

Title: Jiwon Huh: Innovator in Cancer Immunotherapy

Introduction

Jiwon Huh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on enhancing the immune response against tumors, which is crucial for developing effective cancer therapies.

Latest Patents

Jiwon Huh holds a patent for a groundbreaking invention titled "Combination of a substance modulating tumor immune microenvironment and immunotherapy for the treatment of cancer." This patent describes a novel combination of a substance that suppresses or inhibits the function of extracellular TCTP (translationally controlled tumor protein) and a cancer immunotherapeutic agent, preferably an immune checkpoint inhibitor. The invention aims to activate or enhance anti-tumor immune cells, such as T cells and natural killer (NK) cells, while antagonizing immunosuppressive cells in the tumor immune microenvironment. This combination is useful for treating or preventing cancer and alleviating immune suppression.

Career Highlights

Throughout his career, Jiwon Huh has worked with notable organizations, including Boostimmune, Inc. and the University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in cancer immunotherapy.

Collaborations

Jiwon Huh has collaborated with several professionals in his field, including Gwanghee Lee and Jeonghyun Ryou. These collaborations have further enriched his research and development efforts in cancer treatment.

Conclusion

Jiwon Huh is a key figure in the realm of cancer immunotherapy, with a focus on innovative solutions that enhance the immune response against tumors. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.